Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

302.21 

8.20 2.8%

as of May 19 '22

52 Week Range:

288.12 475.35


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Equity (BVPS) 10.26
10.63
11.92
13.61
13.77
15.63
17.82
18.24
20.08
23.23
29.68
growth rate 3.6% 12.1% 14.2% 1.2% 13.5% 14.0% 2.4% 10.1% 15.7% 27.8%
Earnings BIT 92.70
213.30
249.30
183.30
130.10
228.90
239.20
250.90
296.00
420.10
764.00
growth rate 130.1% 16.9% -26.5% -29.0% 75.9% 4.5% 4.9% 18.0% 41.9% 81.9%
Avg.PE 18.59
24.33
31.15
31.27
49.62
42.78
43.09
38.04
49.23
61.41
48.74
growth rate 30.9% 28.0% 0.4% 58.7% -13.8% 0.7% -11.7% 29.4% 24.7% -20.6%
ROA 5.61
5.45
6.94
7.61
5.68
8.42
8.42
10.77
11.19
13.48
21.67
growth rate -2.9% 27.3% 9.7% -25.4% 48.2% 0.0% 27.9% 3.9% 20.5% 60.8%
ROE 11.79
11.66
13.73
13.64
9.65
13.41
12.57
15.46
16.28
20.20
31.59
growth rate -1.1% 17.8% -0.7% -29.3% 39.0% -6.3% 23.0% 5.3% 24.1% 56.4%
ROIC 8.86
8.50
10.19
10.61
8.05
11.14
10.98
13.82
14.05
17.23
27.60
growth rate -4.1% 19.9% 4.1% -24.1% 38.4% -1.4% 25.9% 1.7% 22.6% 60.2%
Cur. Ratio 1.94
2.13
2.75
2.61
2.14
2.66
2.66
3.15
3.10
2.73
2.93
growth rate 9.8% 29.1% -5.1% -18.0% 24.3% 0.0% 18.4% -1.6% -11.9% 7.3%
Quick Ratio 0.98
1.33
1.79
1.72
1.45
1.67
1.75
2.21
2.22
1.99
2.11
growth rate 35.7% 34.6% -3.9% -15.7% 15.2% 4.8% 26.3% 0.5% -10.4% 6.0%
Leverage 2.14
2.15
1.84
1.75
1.66
1.54
1.46
1.42
1.49
1.51
1.42
growth rate 0.5% -14.4% -4.9% -5.1% -7.2% -5.2% -2.7% 4.9% 1.3% -6.0%
Balance Sheet Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 155.10
175.00
185.70
179.00
181.40
200.50
253.20
288.20
319.30
385.30
489.00
growth rate 12.8% 6.1% -3.6% 1.3% 10.5% 26.3% 13.8% 10.8% 20.7% 26.9%
Acct.Payable 154.40
102.90
108.00
103.10
119.80
122.00
138.10
130.40
156.80
213.10
232.20
growth rate -33.4% 5.0% -4.5% 16.2% 1.8% 13.2% -5.6% 20.3% 35.9% 9.0%
Cur.Assets 472.00
557.30
650.70
659.10
673.70
641.90
743.50
894.40
1,058.70
1,373.70
1,742.00
growth rate 18.1% 16.8% 1.3% 2.2% -4.7% 15.8% 20.3% 18.4% 29.8% 26.8%
Total Assets 1,399.10
1,564.00
1,671.60
1,669.70
1,695.10
1,716.70
1,862.80
1,978.90
2,341.40
2,793.80
3,313.80
growth rate 11.8% 6.9% -0.1% 1.5% 1.3% 8.5% 6.2% 18.3% 19.3% 18.6%
Cash 91.80
161.90
230.00
255.30
274.60
203.00
235.90
337.40
439.10
615.50
762.60
growth rate 76.4% 42.1% 11.0% 7.6% -26.1% 16.2% 43.0% 30.1% 40.2% 23.9%
Inventory 151.80
67.70
72.10
181.50
181.10
199.30
215.20
214.50
235.70
321.30
378.40
growth rate -55.4% 6.5% 151.7% -0.2% 10.1% 8.0% -0.3% 9.9% 36.3% 17.8%
Cur.Liabilities 243.20
261.80
236.90
252.50
314.30
241.00
279.50
283.70
341.60
503.40
594.10
growth rate 7.7% -9.5% 6.6% 24.5% -23.3% 16.0% 1.5% 20.4% 47.4% 18.0%
Liabilities 744.20
835.10
765.20
712.80
671.20
599.20
582.90
582.60
768.20
939.30
978.40
growth rate 12.2% -8.4% -6.9% -5.8% -10.7% -2.7% -0.1% 31.9% 22.3% 4.2%
LT Debt 299.30
378.80
371.30
311.70
230.90
226.20
197.00
196.00
256.40
258.50
208.80
growth rate 26.6% -2.0% -16.1% -25.9% -2.0% -12.9% -0.5% 30.8% 0.8% -19.2%
Equity 654.90
728.90
906.40
956.90
1,023.90
1,117.50
1,279.90
1,396.30
1,573.20
1,854.50
2,335.40
growth rate 11.3% 24.4% 5.6% 7.0% 9.1% 14.5% 9.1% 12.7% 17.9% 25.9%
Common Shares 74.00
71.00
71.00
72.00
73.00
75.00
75.00
75.00
75.00
75.00
76.00
growth rate -4.1% 0.0% 1.4% 1.4% 2.7% 0.0% 0.0% 0.0% 0.0% 1.3%
Cash Flow Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 95.40
131.30
151.90
111.90
131.60
170.20
130.80
104.70
126.40
174.40
253.40
growth rate 37.6% 15.7% -26.3% 17.6% 29.3% -23.2% -20.0% 20.7% 38.0% 45.3%
Cash Dividends 23.20
24.90
26.80
29.10
32.40
35.80
39.10
42.10
45.10
48.10
51.10
growth rate 7.3% 7.6% 8.6% 11.3% 10.5% 9.2% 7.7% 7.1% 6.7% 6.2%
Cash From OA 130.70
187.40
220.50
182.90
212.40
219.40
263.30
288.60
367.20
472.50
584.00
growth rate 43.4% 17.7% -17.1% 16.1% 3.3% 20.0% 9.6% 27.2% 28.7% 23.6%
FCF per Share 0.68
0.77
1.06
1.08
1.04
0.64
1.38
2.55
2.86
3.59
4.49
growth rate 13.2% 37.7% 1.9% -3.7% -38.5% 115.6% 84.8% 12.2% 25.5% 25.1%
Sale Purchase of Stock 5.80
-4.70
-5.20
17.10
15.90
29.70
43.90
growth rate -100.0% 0.0% 100.0% -7.0% 86.8% 47.8%
FCF 33.00
55.00
65.00
70.00
80.00
49.00
133.00
184.00
241.00
298.00
331.00
growth rate 66.7% 18.2% 7.7% 14.3% -38.8% 171.4% 38.4% 31.0% 23.7% 11.1%
Income Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Sales 1,192.30
1,266.40
1,368.40
1,421.40
1,399.80
1,509.10
1,599.10
1,717.40
1,839.90
2,146.90
2,831.60
growth rate 6.2% 8.1% 3.9% -1.5% 7.8% 6.0% 7.4% 7.1% 16.7% 31.9%
Op.Income 75.50
80.70
112.30
183.30
130.10
228.90
239.20
250.90
296.00
420.10
764.00
growth rate 6.9% 39.2% 63.2% -29.0% 75.9% 4.5% 4.9% 18.0% 41.9% 81.9%
IBT 92.70
113.40
147.10
174.30
121.90
198.00
231.60
248.30
300.70
418.70
769.00
growth rate 22.3% 29.7% 18.5% -30.1% 62.4% 17.0% 7.2% 21.1% 39.2% 83.7%
Net Income 75.50
80.70
112.30
127.10
95.60
143.60
150.70
206.90
241.70
346.20
661.80
growth rate 6.9% 39.2% 13.2% -24.8% 50.2% 4.9% 37.3% 16.8% 43.2% 91.2%
EPS 1.08
1.15
1.57
1.75
1.30
1.91
1.99
2.74
3.21
4.57
8.67
growth rate 6.5% 36.5% 11.5% -25.7% 46.9% 4.2% 37.7% 17.2% 42.4% 89.7%
Gross Profit 339.30
464.60
434.70
447.80
455.80
501.40
512.90
545.40
605.70
767.80
1,175.80
growth rate 36.9% -6.4% 3.0% 1.8% 10.0% 2.3% 6.3% 11.1% 26.8% 53.1%
R&D 29.10
33.20
37.90
37.30
34.10
36.80
39.10
40.30
38.90
46.90
52.80
growth rate 14.1% 14.2% -1.6% -8.6% 7.9% 6.3% 3.1% -3.5% 20.6% 12.6%

Quarterly Statements

Item Name Mar '21 Jun '21 Sep '21 Dec '21 Mar '22
Earnings BIT 178.30
210.20
183.70
189.90
growth rate 17.9% -12.6% 3.4%
Balance Sheet Mar '21 Jun '21 Sep '21 Dec '21 Mar '22
Acct.Receivable 465.70
480.50
476.40
489.00
498.70
growth rate 3.2% -0.9% 2.6% 2.0%
Acct.Payable 204.30
205.10
207.70
232.20
248.20
growth rate 0.4% 1.3% 11.8% 6.9%
Cur.Assets 1,327.00
1,477.00
1,598.30
1,742.00
1,690.50
growth rate 11.3% 8.2% 9.0% -3.0%
Total Assets 2,739.70
2,933.50
3,142.60
3,313.80
3,294.70
growth rate 7.1% 7.1% 5.5% -0.6%
Cash 483.70
576.20
688.00
762.60
667.70
growth rate 19.1% 19.4% 10.8% -12.4%
Inventory 310.20
345.20
353.80
378.40
416.50
growth rate 11.3% 2.5% 7.0% 10.1%
Cur.Liabilities 482.80
472.60
558.60
594.10
584.80
growth rate -2.1% 18.2% 6.4% -1.6%
Liabilities 910.70
900.90
940.30
978.40
968.50
growth rate -1.1% 4.4% 4.1% -1.0%
LT Debt 252.30
251.80
209.90
208.80
208.30
growth rate -0.2% -16.6% -0.5% -0.2%
Equity 1,829.00
2,032.60
2,202.30
2,335.40
2,326.20
growth rate 11.1% 8.4% 6.0% -0.4%
Common Shares 18.80
18.80
18.80
18.80
18.80
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '21 Jun '21 Sep '21 Dec '21 Mar '22
Capital Expenditures 54.70
56.90
65.30
76.50
growth rate 4.0% 14.8% 17.2%
Cash Dividends 12.60
12.60
12.60
13.30
growth rate 0.0% 0.0% 5.6%
Cash From OA 88.70
144.40
190.10
160.80
151.20
growth rate 62.8% 31.7% -15.4% -6.0%
Sale Purchase of Stock
growth rate
FCF 34.00
87.50
124.80
84.30
growth rate 157.4% 42.6% -32.5%
Income Statement Mar '21 Jun '21 Sep '21 Dec '21 Mar '22
Sales 670.70
723.60
706.50
730.80
720.00
growth rate 7.9% -2.4% 3.4% -1.5%
Op.Income 178.30
210.20
183.70
189.90
growth rate 17.9% -12.6% 3.4%
IBT 179.90
219.60
187.60
181.90
growth rate 22.1% -14.6% -3.0%
Net Income 151.20
187.30
175.60
147.70
173.80
growth rate 23.9% -6.3% -15.9% 17.7%
EPS
growth rate
Gross Profit 271.90
315.10
288.20
300.60
284.60
growth rate 15.9% -8.5% 4.3% -5.3%
R&D 12.20
13.80
13.10
13.70
14.60
growth rate 13.1% -5.1% 4.6% 6.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A+ (97.21)

YOY Growth Grade:

B (77.96)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 36.81 33.69 32.80
EPS / Growth 14.4% 8.97 27.6%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 16.7%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 14.4% 19.6% 19.6%
Future PE 28.76 36.24 36.24
Future EPS 34.38 53.49 53.49
Value Price
MOS %
244.40
-19.1%
479.12
58.5%
479.12
58.5%
MOS Price 122.20 239.56 239.56
IRT 12.31 10.47 10.47

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.